Algert Global’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.9M | Buy |
530,914
+321,594
| +154% | +$5.99M | 0.21% | 133 |
|
|
2025
Q1 | $4.01M | Buy |
209,320
+119,784
| +134% | +$2.3M | 0.1% | 348 |
|
|
2024
Q4 | $3.23M | Buy |
89,536
+52,423
| +141% | +$1.89M | 0.08% | 437 |
|
|
2024
Q3 | $1.57M | Sell |
37,113
-8,150
| -18% | -$346K | 0.04% | 638 |
|
|
2024
Q2 | $1.82M | Buy |
45,263
+6,150
| +16% | +$248K | 0.06% | 495 |
|
|
2024
Q1 | $1.39M | Buy |
39,113
+27,970
| +251% | +$990K | 0.05% | 528 |
|
|
2023
Q4 | $330K | Sell |
11,143
-31,500
| -74% | -$933K | 0.01% | 920 |
|
|
2023
Q3 | $886K | Buy |
42,643
+9,270
| +28% | +$193K | 0.04% | 588 |
|
|
2023
Q2 | $819K | Sell |
33,373
-59,253
| -64% | -$1.45M | 0.04% | 701 |
|
|
2023
Q1 | $3.76M | Buy |
92,626
+27,380
| +42% | +$1.11M | 0.18% | 160 |
|
|
2022
Q4 | $2.93M | Buy |
65,246
+4,065
| +7% | +$183K | 0.16% | 182 |
|
|
2022
Q3 | $2.93M | Buy |
61,181
+2,189
| +4% | +$105K | 0.18% | 159 |
|
|
2022
Q2 | $3.49M | Buy |
58,992
+11,261
| +24% | +$667K | 0.26% | 61 |
|
|
2022
Q1 | $5.55M | Buy |
47,731
+13,412
| +39% | +$1.56M | 0.36% | 24 |
|
|
2021
Q4 | $5.17M | Sell |
34,319
-2,099
| -6% | -$316K | 0.65% | 2 |
|
|
2021
Q3 | $4.35M | Buy |
36,418
+2,338
| +7% | +$279K | 0.58% | 3 |
|
|
2021
Q2 | $3.32M | Buy |
34,080
+19,866
| +140% | +$1.93M | 1.12% | 4 |
|
|
2021
Q1 | $1.25M | Sell |
14,214
-2,969
| -17% | -$262K | 0.4% | 82 |
|
|
2020
Q4 | $1.64M | Sell |
17,183
-20
| -0.1% | -$1.91K | 0.47% | 67 |
|
|
2020
Q3 | $1.95M | Buy |
17,203
+840
| +5% | +$95.4K | 0.62% | 39 |
|
|
2020
Q2 | $1.62M | Buy |
16,363
+11,840
| +262% | +$1.17M | 0.55% | 44 |
|
|
2020
Q1 | $291K | Buy |
+4,523
| New | +$291K | 0.12% | 255 |
|